Tarsus Pharmaceuticals Inc · TARS.US · Annual · 2025-12-31 · compared with 2024-12-31

Balance scale

Assets on one bar, liabilities stacked with equity on the other. Both use the same scale.

Assets $562.16M − (Liabilities $218.73M + Equity $343.43M) = $0.00 · in balance

Composition

Named lines under 3% of the side are folded into Other. Each stack equals its reported total.

High-level mix

At most five slices. Assets use blue. Liabilities use orange and slate. Equity is green.

Change from prior period

Each step is the change in that group. The last bar is the selected period total.

Recent periods

Last eight periods. Cash, receivables, inventory, and PPE are assets. Total debt is orange. Equity is green.

Line detail

Percents use the same slices as the composition charts. The bar shows magnitude within the side.

Side
Group
Amount
% of side
Change
Change %
Assets
Cash
$183.64M
32.7%
$88.82M
93.7%
Assets
Receivables
$87.11M
15.5%
$39.05M
81.3%
Assets
PPE
$21.75M
3.9%
$18.88M
658.7%
Assets
Other
$269.66M
48.0%
$38.42M
16.6%
Liabilities + Equity
Long-term debt
$72.44M
12.9%
$593.00K
0.8%
Liabilities + Equity
Other liabilities
$146.29M
26.0%
$65.68M
81.5%
Liabilities + Equity
Equity
$343.43M
61.1%
$118.89M
53.0%